Toy Guns, Real Danger: An Update on Pediatric Injury Patterns Related to Nonpowder Weapons

Robert J McLoughlin1, Alyssa Stetson2, Jonathan Green1

  • 1University of Massachusetts Medical School, Department of Surgery, Worcester, MA.

Insights

Nonpowder gun injuries in children are serious, often requiring surgery and causing lasting harm like blindness. These weapons are not toys and access should be limited.

Area of Science:

  • Pediatric Trauma
  • Injury Prevention
  • Public Health

Background:

  • Nonpowder guns, including BB and air guns, have evolved, increasing their injury potential.
  • Characterizing pediatric injuries from these weapons is crucial for prevention and treatment.

Purpose of the Study:

  • To analyze the demographics of children injured by nonpowder weapons.
  • To identify the types of injuries sustained by pediatric victims of nonpowder weapons.

Main Methods:

  • Cross-sectional analysis of the Kids' Inpatient Database (2006, 2009, 2012).
  • Identification of air gun injuries using external cause of injury codes.
  • Analysis of patient demographics and injury types using ICD-9 codes and national estimates.

Main Results:

  • 1028 pediatric admissions for nonpowder weapon injuries.
  • Victims were predominantly male (87.0%), non-Hispanic white (52.3%), from the South (47.3%), and low-income (39.2%).
  • Common injuries included open wounds (40.3%), contusions (22.5%), intracranial injury (9.1%), and blindness (3.3%); 50% required major surgery.

Conclusions:

  • Nonpowder weapons cause severe, lasting injuries in children, including paralysis and blindness.
  • These injuries frequently necessitate surgical intervention, highlighting that these weapons are not toys.
  • Legislation and further research are needed to restrict children's access to nonpowder weapons.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
221
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
222
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
373
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
181
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
209
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
160